Rangan Maitra

1.4k total citations
51 papers, 1.1k citations indexed

About

Rangan Maitra is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Rangan Maitra has authored 51 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pharmacology, 28 papers in Cellular and Molecular Neuroscience and 19 papers in Molecular Biology. Recurrent topics in Rangan Maitra's work include Cannabis and Cannabinoid Research (21 papers), Neuroscience and Neuropharmacology Research (12 papers) and Apelin-related biomedical research (10 papers). Rangan Maitra is often cited by papers focused on Cannabis and Cannabinoid Research (21 papers), Neuroscience and Neuropharmacology Research (12 papers) and Apelin-related biomedical research (10 papers). Rangan Maitra collaborates with scholars based in United States, France and Canada. Rangan Maitra's co-authors include Joshua W. Hamilton, Scott P. Runyon, Herbert H. Seltzman, Rodney W. Snyder, Yanan Zhang, Shan Huang, Brian P. Gilmour, Danni L. Harris, George Amato and Brian F. Thomas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemical Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Rangan Maitra

50 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rangan Maitra United States 22 489 406 404 196 96 51 1.1k
Sonia Hernández‐Tiedra Spain 15 816 1.7× 520 1.3× 276 0.7× 265 1.4× 86 0.9× 15 1.6k
Yasuhide Morioka Japan 19 201 0.4× 392 1.0× 133 0.3× 103 0.5× 34 0.4× 50 973
Vincent A. Florio United States 18 284 0.6× 1.4k 3.5× 377 0.9× 101 0.5× 105 1.1× 20 1.7k
Michael A. Trevethick United Kingdom 19 377 0.8× 376 0.9× 242 0.6× 238 1.2× 31 0.3× 36 1.2k
Laura Revel Italy 17 111 0.2× 266 0.7× 356 0.9× 170 0.9× 87 0.9× 44 806
Anju Preet United States 15 468 1.0× 639 1.6× 177 0.4× 174 0.9× 123 1.3× 21 1.3k
Concepción Villanueva Spain 8 760 1.6× 318 0.8× 280 0.7× 215 1.1× 97 1.0× 10 1.1k
R. Roncucci Italy 19 163 0.3× 377 0.9× 209 0.5× 127 0.6× 113 1.2× 71 1.2k
Christian Euchenhofer Germany 13 328 0.7× 285 0.7× 127 0.3× 81 0.4× 126 1.3× 13 1.1k
M. Lecomte France 15 330 0.7× 342 0.8× 85 0.2× 153 0.8× 106 1.1× 37 982

Countries citing papers authored by Rangan Maitra

Since Specialization
Citations

This map shows the geographic impact of Rangan Maitra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rangan Maitra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rangan Maitra more than expected).

Fields of papers citing papers by Rangan Maitra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rangan Maitra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rangan Maitra. The network helps show where Rangan Maitra may publish in the future.

Co-authorship network of co-authors of Rangan Maitra

This figure shows the co-authorship network connecting the top 25 collaborators of Rangan Maitra. A scholar is included among the top collaborators of Rangan Maitra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rangan Maitra. Rangan Maitra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amato, George, et al.. (2023). Discovery of 1,3-disubstituted pyrazole peripheral cannabinoid receptor partial agonists. Bioorganic & Medicinal Chemistry Letters. 93. 129430–129430. 3 indexed citations
2.
Narayanan, Sanju, et al.. (2022). Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin receptor. Bioorganic & Medicinal Chemistry. 66. 116789–116789. 5 indexed citations
3.
Harper, Kathryn M., Sheryl S. Moy, Scott P. Runyon, et al.. (2020). Aplnr knockout mice display sex-specific changes in conditioned fear. Behavioural Brain Research. 400. 113059–113059. 1 indexed citations
4.
Clark, Stewart D., et al.. (2020). Behavioral assessment of rimonabant under acute and chronic conditions. Behavioural Brain Research. 390. 112697–112697. 18 indexed citations
5.
Scheiner, Matthias, Sandra Gunesch, Matthias Hoffmann, et al.. (2019). Dual-Acting Cholinesterase–Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo. Journal of Medicinal Chemistry. 62(20). 9078–9102. 39 indexed citations
6.
Amato, George, Amruta Manke, Robert W. Wiethe, et al.. (2018). Synthesis and pharmacological characterization of functionalized 6-piperazin-1-yl-purines as cannabinoid receptor 1 (CB1) inverse agonists. Bioorganic & Medicinal Chemistry. 26(15). 4518–4531. 4 indexed citations
7.
Seltzman, Herbert H., et al.. (2017). Metabolic Profiling of CB1 Neutral Antagonists. Methods in enzymology on CD-ROM/Methods in enzymology. 593. 199–215. 14 indexed citations
8.
Decker, Ann M., et al.. (2017). Development and validation of a high-throughput calcium mobilization assay for the orphan receptor GPR88. Journal of Biomedical Science. 24(1). 23–23. 13 indexed citations
9.
Narayanan, Sanju, Rangan Maitra, Jeffrey R. Deschamps, et al.. (2016). Discovery of a novel small molecule agonist scaffold for the APJ receptor. Bioorganic & Medicinal Chemistry. 24(16). 3758–3770. 24 indexed citations
10.
Zhang, Yanan, Herbert H. Seltzman, Rodney W. Snyder, et al.. (2016). Pyrazole antagonists of the CB1 receptor with reduced brain penetration. Bioorganic & Medicinal Chemistry. 24(5). 1063–1070. 17 indexed citations
11.
Carroll, F. Ivy, Chad M. Kormos, Rangan Maitra, et al.. (2015). Design, synthesis, and pharmacological evaluation of JDTic analogs to examine the significance of the 3- and 4-methyl substituents. Bioorganic & Medicinal Chemistry. 23(19). 6379–6388. 14 indexed citations
12.
Smith, Terika P., Alyssa M. Schlenz, Jeffrey Schatz, Rangan Maitra, & Sarah M. Sweitzer. (2014). Modulation of pain in pediatric sickle cell disease: Understanding the balance between endothelin mediated vasoconstriction and apelin mediated vasodilation. Blood Cells Molecules and Diseases. 54(2). 155–159. 14 indexed citations
13.
Zhang, Yanyan, Rangan Maitra, Danni L. Harris, et al.. (2014). Identifying structural determinants of potency for analogs of apelin-13: Integration of C-terminal truncation with structure–activity. Bioorganic & Medicinal Chemistry. 22(11). 2992–2997. 31 indexed citations
14.
Maitra, Rangan, et al.. (2013). A Rapid Membrane Potential Assay to Monitor CFTR Function and Inhibition. SLAS DISCOVERY. 18(9). 1132–1137. 19 indexed citations
15.
Qiu, Chunfang, et al.. (2012). Decreased Maternal Plasma Apelin Concentrations in Preeclampsia. Hypertension in Pregnancy. 31(4). 398–404. 36 indexed citations
16.
Wiley, Jenny L., Julie A. Marusich, Yanan Zhang, et al.. (2012). Structural analogs of pyrazole and sulfonamide cannabinoids: Effects on acute food intake in mice. European Journal of Pharmacology. 695(1-3). 62–70. 11 indexed citations
17.
Zhang, Yanan, et al.. (2011). Towards rational design of cannabinoid receptor 1 (CB1) antagonists for peripheral selectivity. Bioorganic & Medicinal Chemistry Letters. 21(19). 5711–5714. 28 indexed citations
18.
Maitra, Rangan, et al.. (2009). Inhibition of NFκB by the natural product Withaferin A in cellular models of Cystic Fibrosis inflammation. Journal of Inflammation. 6(1). 15–15. 80 indexed citations
19.
Maitra, Rangan & Joshua W. Hamilton. (2007). Altered Biogenesis of ΔF508-CFTR Following Treatment with Doxorubicin. Cellular Physiology and Biochemistry. 20(5). 465–472. 7 indexed citations
20.
Benbow, Ulrike, Rangan Maitra, Joshua W. Hamilton, & Constance Brinckerhoff. (1999). Selective Inhibition of Collagenase‐1, Gelatinase A, and Gelatinase B by Chemotherapeutic Agents. Annals of the New York Academy of Sciences. 878(1). 662–664. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sonia Hernández‐Tiedra Breakdown of academic impact, for papers by Yasuhide Morioka Breakdown of academic impact, for papers by Vincent A. Florio Breakdown of academic impact, for papers by Michael A. Trevethick Breakdown of academic impact, for papers by Laura Revel Breakdown of academic impact, for papers by Anju Preet Breakdown of academic impact, for papers by Concepción Villanueva Breakdown of academic impact, for papers by R. Roncucci Breakdown of academic impact, for papers by Christian Euchenhofer Breakdown of academic impact, for papers by M. Lecomte
Rankless by CCL
2026